SCHEMBL26099062

SCHEMBL26099062

COC[C@@H]1CCCN1C(=O)Cc1ccc(NCc2ccc(OC)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.53
ROCK1 Q13464 1/20 0.53
HRH3 Q9Y5N1 1/20 0.51
GAA P10253 2/20 0.48
HPGD P15428 1/20 0.48
PKM P14618 1/20 0.47
FFAR1 O14842 1/20 0.46
OPRK1 P41145 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 1/20 0.46
RAB9A P51151 3/20 0.45
POLB P06746 1/20 0.45
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26101541 0.91 HRH3 (0.52) HRH3GAAHPGDPKMFFAR1
SCHEMBL26099055 0.90 ROCK2 (0.53) ROCK2ROCK1HRH3HPGDOPRK1
SCHEMBL26101993 0.88 SMN1; SMN2 (0.54) ROCK2ROCK1HRH3GAAHPGD
SCHEMBL26097901 0.82 DPP4 (0.58) GAAHPGDPKMFFAR1
SCHEMBL26103558 0.82 DPP4 (0.58) GAAHPGDPKMFFAR1
SCHEMBL26100222 0.79 SMN1; SMN2 (0.55) ROCK2HRH3GAAHPGDPKM
SCHEMBL26102205 0.79 SMN1; SMN2 (0.55) ROCK2HRH3GAAHPGDPKM
SCHEMBL26101450 0.78 MAPT (0.50) GAAHPGDFFAR1OPRK1SMN1; SMN2
SCHEMBL26101681 0.78 RAB9A (0.50) ROCK2ROCK1HRH3HPGDRAB9A
SCHEMBL26098711 0.78 SMN1; SMN2 (0.66) GAAHPGDFFAR1SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 ROCK2 1105/4885ROCK1 1351/4885HRH3 647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.